Affinivax, Inc.
CAMBRIDGE, MA · Founded 2014 · CIK 0001726931 · Biotech · Acquired
Synthetic glycan-conjugate vaccine platform for infectious diseases and cancer
gsk.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $233M
- 2 Form D · Jan 2021
- 69 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 27
- 6 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,987,455 | |
| Private capital raised | Form D · SEC | $225,999,698 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2789 | Zylo Therapeutics Inc. | — | $4.9M |
| 2790 | Arbor Biotechnologies | — | $227M |
| 2791 | Metsera | — | $215M |
| 2792 | Affinivax, Inc. | — | $233M |
| 2793 | Forge Biologics Holdings, LLC | — | $160M |
| 2794 | Empress Therapeutics | — | — |
| 2795 | Octant Bio | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Steven AltschulerDirector
- Steven BruggerDirector · Executive Officer
- Andrew HackDirector
- Frances HellerDirector
- Richard MalleyDirector
- Robert MoreDirector
- George SiberDirector
- Kamran TavangarExecutive Officer
Patents
- Multivalent Pneumococcal Vaccinesapplication
- Multivalent Pneumococcal Vaccinesapplication
- Multivalent Pneumococcal Vaccinesgranted
- Multivalent Pneumococcal Vaccinesgranted
- Multivalent Pneumococcal Vaccinesgranted
- Immunogenic Compositionsapplication
- Coronavirus Vaccineapplication
- Multivalent Pneumococcal Vaccinesgranted
- Immunogenic Compositionsgranted
- Multivalent Pneumococcal Vaccinesgranted
- Coronavirus Vaccineapplication
- Multivalent Pneumococcal Vaccinesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.